TScan Therapeutics TCRX
NASDAQ TCRX
$0.78 +0.00 (+0.43%)
At close: Aug 21, 2026 · 4:00 PM EDT

TScan Therapeutics (TCRX) Shares Outstanding (Entity) (2020 - 2026)

TScan Therapeutics (TCRX) Shares Outstanding (Entity) (2020 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 253.35 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 102.80 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 62.54 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 399.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 113.02 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 133.73 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 252.88 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 218.28 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 575.47 Mn
10 TScan Therapeutics 100.62 Mn 100.62 Mn - 129.95 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 129.95 Mn
Mar 31, 2026 129.91 Mn
Dec 31, 2025 129.78 Mn
Sep 30, 2025 129.84 Mn
Jun 30, 2025 129.73 Mn
Mar 31, 2025 129.68 Mn
Dec 31, 2024 111.99 Mn
Sep 30, 2024 118.70 Mn
Jun 30, 2024 113.43 Mn
Mar 31, 2024 94.88 Mn
Dec 31, 2023 65.60 Mn
Sep 30, 2023 94.83 Mn
Jun 30, 2023 43.54 Mn
Mar 31, 2023 19.48 Mn
Dec 31, 2022 24.05 Mn
Sep 30, 2022 24.07 Mn
Jun 30, 2022 24.06 Mn
Mar 31, 2022 23.97 Mn
Dec 31, 2021 11.66 Mn
Sep 30, 2021 23.76 Mn